-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$63.1729.95% Upside
Disc Medicine, Inc. Frequently Asked Questions
-
What analysts cover Disc Medicine, Inc.?
Disc Medicine, Inc. has been rated by research analysts at H.C. Wainwright, Wells Fargo, Raymond James, BMO Capital, Stifel Nicolaus, Wedbush in the past 90 days.